logo
logo
Sign in

Injection of low molecular weight heparin (LMWH) prevents blood clots from forming through the abdomen

avatar
Vivek Vishwakarma
Injection of low molecular weight heparin (LMWH) prevents blood clots from forming through the abdomen

Low molecular weight heparin is a type of anticoagulant that is widely used. It was initially created to treat severe allergic rhinitis. It is now used as an anticoagulant to prevent blood clots and thrombosis, to treat hemorrhagic stroke, and to prevent varicose veins and thrombotic femoral thrombosis. Low molecular weight heparin's major role is to prevent platelet clumping and bleeding, and it has outstanding anti-platelet and blood-clotting characteristics. It is extremely safe and has very few major adverse effects. As a result, it is quite beneficial for all types of bleeding disorders.

The most commonly used low molecular weight heparin formulations are presently on the market. Acute hemorrhagic stroke, myocardial infarction, rheumatic fever, acne, vitiligo, sepsis, thrombocytopenia, congenital heart disease, psoriatic arthritis, lupus, rheumatoid arthritis, autoimmune thyroid disease, atrophic vagal disorder, and other connective tissue disorders can all be treated with them. For example, in December 2020, the National Comprehensive Cancer Network, a non-profit organisation in the United States, revealed the results of its clinical trials concluding that low molecular weight heparin is the most effective solution for the treatment of cancer-associated venous thromboembolism (VTE). Because these products are incredibly efficient medicines, they should only be used under medical supervision because they can harm healthy cells in the body. They can induce severe bleeding and interfere with the absorption of other drugs.

Read More: https://bit.ly/3jfLRyg

collect
0
avatar
Vivek Vishwakarma
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more